Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

25 May 2016 - 27 May 2016
06 Jun 2016 - 09 Jun 2016
22 Jun 2016 - 24 Jun 2016

Small Molecule TWEAK-Fn14 Inhibitors Block Cancer Growth

By BiotechDaily International staff writers
Posted on 21 Nov 2013
Print article
Image: Immunohistochemistry of TWEAK in human brain tissue (Photo courtesy of Sigma-Aldrich Inc.).
Image: Immunohistochemistry of TWEAK in human brain tissue (Photo courtesy of Sigma-Aldrich Inc.).
Drug developers have identified a series of small molecules that block the interaction of the cytokine TWEAK (TNF-related weak inducer of apoptosis) with its receptor Fn14 (fibroblast growth factor-inducible 14), which slows growth of brain, breast, pancreatic, esophageal, lung, and liver cancers.

TWEAK is a cytokine protein that belongs to the tumor necrosis factor (TNF) family and is a ligand for the Fn14/TWEAKR receptor. This cytokine has overlapping signaling functions with TNF, but displays a much wider tissue distribution. TWEAK can induce apoptosis via multiple pathways of cell death in a cell type-specific manner. This cytokine is also found to promote proliferation and migration of endothelial cells, and thus acts as a regulator of angiogenesis. Overexpression of TWEAK-Fn14 activation has been linked to tissue damage and degradation, including autoimmune diseases, as well as the survival, migration, and invasion of cancer cells.

Investigators at the Translational Genomics Research Institute (Phoenix, AZ, USA) used computer-generated protein-protein docking models to design a targeted library of small molecules predicted to disrupt the TWEAK-Fn14 interaction.

Results published in the November 8, 2013, issue of the Journal of Biological Chemistry described a group of 129 small molecules that produced up to 37% inhibition of TWEAK-Fn14 binding. Four molecules were found to be particularly potent; including compound L524-0366, which completely suppressed TWEAK-induced brain cancer-cell migration without any potential cytotoxic effects.

"Our results show that the TWEAK-Fn14 interaction is a viable drug target, and they provide the foundation for further exploration of this system in researching invasive cancers," said co-senior author Dr. Nhan Tran, associate professor of cancer and cell biology at the Translational Genomics Research Institute. "Because of its unique qualities and association with acute injuries, this drug-like molecule not only could benefit cancer patients, but also might be applied to patients with autoimmunity, heart disease like atherosclerosis, and rheumatoid arthritis."

Related Links:

Translational Genomics Research Institute



Print article

Channels

Genomics/Proteomics

view channel
Image: Follicular helper T-cells (TFH cells, shown in blue) play a crucial role in the maturation of antibody-producing B-cells (shown in green). Activated B-cells give rise germinal centers (shown in red), where mature B-cells proliferate and produce highly specific antibodies against pathogens. Top left: normal germinal center in a mouse tonsil. All others: Germinal centers fail to form when the interaction between ICOS and TBK1 is interrupted (Photo courtesy of Dr. Kok-Fai Kong, La Jolla Institute for Allergy and Immunology).

Molecular Pathway Controlling High-affinity Antibody Production Identified

A molecular pathway has been identified that controls formation of follicular helper T-cells (TFH cells) germinal centers and production of high-affinity antibodies through interaction with the inducible... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Lab Technologies

view channel

Huge Modifiable Biomedical Database to Be Available on the Wikidata Site

Genome researchers are exploiting the power of the open Internet community Wikipedia database to create a comprehensive resource for geneticists, molecular biologists, and other interested life scientists. While efficiency in generating scientific data improves almost daily, applying meaningful relationships between... Read more

Business

view channel

European Biotech Agreement to Promote Antigen-Drug Conjugation Technology

Two European biotech companies have joined forces to exploit and commercialize an innovative, site-specific ADC (antigen-drug conjugate) conjugation technology. ProBioGen (Berlin, Germany), a company specializing in the development and manufacture of complex glycoproteins and Eucodis Bioscience (Vienna, Austria), a... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.